Methergin (Methylergometrine Maleate)

Methergin is used in obstetric care to manage uterine bleeding and support labor.

• Postpartum hemorrhage: reduces excessive bleeding after childbirth by stimulating uterine contraction.
• Uterine bleeding after delivery: controls ongoing bleeding when uterine tone is inadequate.
• Induction of labor (where indicated): promotes cervical ripening and uterine contractions to initiate labor.

• Methylergometrine maleate acts as a partial agonist at serotonin (5‑HT2) and alpha‑adrenergic receptors in uterine smooth muscle. This dual receptor activity increases intracellular calcium, enhancing muscle tone and producing sustained uterine contractions that help achieve hemostasis and facilitate labor progression.

Methergin may cause a range of adverse reactions, ranging from mild to severe.

Common Side Effects

• Nausea: mild to moderate gastrointestinal upset.
• Vomiting: occasional episodes following administration.
• Headache: transient cranial discomfort.
• Hypertension: temporary rise in blood pressure.
• Flushing: skin redness and warmth.
• Abdominal cramping: uterine discomfort.

Serious or Rare Side Effects

• Severe hypertension: marked elevation requiring medical intervention.
• Myocardial ischemia: chest pain or cardiac events.
• Pulmonary edema: fluid accumulation in lungs.
• Cerebral vasospasm: neurological symptoms such as visual disturbances.
• Allergic reaction: rash, itching, or anaphylaxis.
• Thromboembolic events: rare clot formation.

Methergin should be used with careful clinical assessment and monitoring.

• Blood pressure monitoring: check before and after administration due to risk of hypertension.
• Cardiovascular assessment: avoid in patients with known coronary artery disease.
• Pre‑eclampsia caution: contraindicated in severe pre‑eclampsia or eclampsia.
• Dose titration: adjust based on uterine response and maternal vital signs.
• Drug interactions: review concomitant vasoconstrictors or antihypertensives.
• Store at ambient temperature: keep in original packaging, protect from moisture and light.

Methergin can interact with several drug classes, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid)

• Ergotamine-containing products: additive vasoconstriction may precipitate severe hypertension.
• Monoamine oxidase inhibitors (MAOIs): increased risk of hypertensive crisis.

Moderate Interactions (Monitor Closely)

• Antihypertensive agents: may blunt the drug's uterotonic effect and require dose adjustments.
• Beta‑blockers: potential for enhanced cardiovascular effects.
• Calcium channel blockers: may alter uterine contractility response.
• Sympathomimetic drugs: additive increase in blood pressure.
• NSAIDs: may affect renal perfusion when combined with vasoconstriction.